Cullinan Therapeutics (CGEM) Change in Cash: 2020-2024
Historic Change in Cash for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to -$15.4 million.
- Cullinan Therapeutics' Change in Cash rose 138.83% to $33.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$57.7 million, marking a year-over-year decrease of 159.89%. This contributed to the annual value of -$15.4 million for FY2024, which is 73.27% up from last year.
- Per Cullinan Therapeutics' latest filing, its Change in Cash stood at -$15.4 million for FY2024, which was up 73.27% from -$57.7 million recorded in FY2023.
- Cullinan Therapeutics' Change in Cash's 5-year high stood at $104.9 million during FY2020, with a 5-year trough of -$108.4 million in FY2021.
- Its 3-year average for Change in Cash is $7.7 million, with a median of -$15.4 million in 2024.
- Per our database at Business Quant, Cullinan Therapeutics' Change in Cash tumbled by 203.31% in 2021 and then surged by 188.89% in 2022.
- Over the past 5 years, Cullinan Therapeutics' Change in Cash (Yearly) stood at $104.9 million in 2020, then plummeted by 203.31% to -$108.4 million in 2021, then soared by 188.89% to $96.4 million in 2022, then slumped by 159.89% to -$57.7 million in 2023, then spiked by 73.27% to -$15.4 million in 2024.